What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
Over the past 3 months, 6 analysts have published their opinion on Bristol-Myers Squibb (NYSE:BMY) stock. These analysts…
Drugmakers To Raise Prices On At Least 350 Drugs In U.S. In January
Drugmakers including Pfizer Inc PFE.N, GlaxoSmithKline PLC GSK.L, Bristol Myers Squibb BMY.N, AstraZeneca PLC AZN.L and Sanofi SA SASY.PA plan to raise prices in the United States on
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
TRACON Touts Encouraging Objective Response Rates For Mid-Stage Cancer Study
TRACON Pharmaceuticals Inc (NASDAQ:TCON) announced the IDMC for the ongoing ENVASARC Phase 2 pivotal trial recommended continued accrual as…
Bristol-Myers Squibb’s Debt Overview
Shares of Bristol-Myers Squibb Inc. (NYSE:BMY) moved higher by 10.05% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Israeli Ministry Of Health Clears Way For Human Trials Of Allocetra
The Israeli Ministry of Health (MOH) approved a Phase I/II trial of Enlivex Therapeutics Ltd.’s (NASDAQ:ENLV) proprietary immunotherapy drug-candidate AllocetraTM.
AllocetraTM is a cell therapy that uses healthy
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 108 stocks hit new 52-week highs.
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.